スイスの人工血管市場予測　2024-2032年

当レポートはスイスの人工血管市場を分析・予測したInkwood Researchの市場調査レポートです。

Report Overview

KEY FINDINGS
The Switzerland artificial blood vessels market is estimated to prosper at a CAGR of 6.34% over the forecast period of 2024-2032. It is set to reach a revenue of $86.56 million by 2032.

スイスの人工血管市場は、2024年から2032年の予測期間にわたって6.34%のCAGRで繁栄すると推定されています。 2032年までに収益は8,656万ドルに達すると予想されています。

MARKET INSIGHTS
The artificial blood vessels market in Switzerland is witnessing significant growth, primarily amped by the increasing prevalence of aortic diseases. These conditions have become a catalyst for market expansion as they necessitate the development and adoption of advanced vascular solutions. The rising incidence of cardiovascular diseases and related vascular disorders is one of the key enablers of this market. As the population ages and lifestyles change, there is a growing need for effective treatments, further propelling the demand for artificial blood vessels.
Advancements in tissue engineering and regenerative medicine have played a crucial role in the market’s growth. These innovations have led to the creation of more reliable artificial blood vessels capable of better mimicking natural blood vessels’ structure and function. Such advancements improve patient outcomes and expand the potential applications of these devices in treating a variety of vascular conditions.
The growing geriatric population in Switzerland is another significant factor contributing to the market’s expansion. As the elderly population increases, so does the prevalence of age-related vascular disorders. Coupled with lifestyle changes, such as increased rates of obesity and sedentary behavior, the demand for advanced vascular solutions continues to rise. This demographic shift underscores the need for innovative treatments and drives ongoing research and development in the field.
Additionally, a notable trend is the development of 3D bioprinting techniques for customized vascular grafts. This technology enables the creation of patient-specific blood vessels, thereby enhancing the effectiveness and compatibility of treatments. Such personalized approaches are expected to revolutionize the field, offering significant benefits to patients with complex vascular conditions.
The incorporation of nanotechnology and biomimetic materials into artificial blood vessels aims to improve the functionality and longevity of these devices. Nanotechnology can further enhance the mechanical properties and biocompatibility of the vessels, while biomimetic materials can closely replicate the natural environment of blood vessels. These innovations elevate the performance of artificial blood vessels and expand their therapeutic potential.
Therefore, the artificial blood vessels market in Switzerland is on an upward trajectory, driven by the rising prevalence of cardiovascular diseases, advancements in medical technology, and demographic changes. While there are challenges to overcome, such as high costs and regulatory hurdles, ongoing innovations in tissue engineering, 3D bioprinting, and nanotechnology are paving the way for improved treatments. These advancements are leading to better patient outcomes and a brighter future for the artificial blood vessels industry. As these trends continue to evolve, Switzerland is poised to remain a key player in the global artificial blood vessels market.

REPORT SYNOPSIS

SEGMENTATION ANALYSIS
The Switzerland artificial blood vessels market segmentation incorporates the market by type, blood vessel diameter, patient demographics, application, and end-user. The patient demographics segment is further divided into pediatric and adult. For pediatric patients, the development and implementation of artificial blood vessels are important due to congenital heart defects and other vascular conditions that can present early in life. Pediatric artificial blood vessels must be designed to accommodate the growing bodies of children, requiring innovative materials and techniques that allow for growth and adaptability over time.
Additionally, the smaller size of pediatric blood vessels poses specific challenges in surgical procedures and device placement, necessitating specialized skills and technologies to ensure successful outcomes. The market’s focus on this sub-segment is driven by the urgent need to address these unique challenges and improve the quality of life for young patients.
For adult patients, the demand for artificial blood vessels is primarily driven by the prevalence of cardiovascular diseases, including atherosclerosis and aneurysms, which are more common in the aging population. The adult sub-segment also includes patients with lifestyle-related conditions such as diabetes and hypertension, which can exacerbate vascular problems. In response, the market has seen significant advancements in the development of durable and biocompatible materials that can withstand the higher pressures and stresses associated with adult vascular systems.
Moreover, the growing senior population in Switzerland is a key driver for this market sub-segment, as older adults are more likely to require vascular interventions. This demographic trend underscores the importance of continuing innovation and investment in the artificial blood vessels market. Such efforts are essential to meet the increasing demand and enhance treatment outcomes for adult patients.

COMPETITIVE ANALYSIS
Some of the leading players in the Switzerland artificial blood vessels market include Terumo Medical Corporation, W L Gore & Associates, B Braun Melsungen AG, etc.
B Braun Melsungen AG is a global medical and pharmaceutical company specializing in healthcare solutions and products. Their diverse portfolio includes medical devices, pharmaceuticals, and healthcare services, featuring products for infusion therapy, dialysis, and surgical instruments. Serving healthcare professionals and institutions worldwide, the company is headquartered in Hessen, Germany.

Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
2.3. COUNTRY ANALYSIS
2.4. SCOPE OF STUDY
2.5. CRISIS SCENARIO ANALYSIS
2.5.1. IMPACT OF COVID-19 ON THE SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET
2.6. MAJOR MARKET FINDINGS
2.6.1. AORTIC DISEASES INCREASE IS SEEN AS A CATALYST FOR MARKET GROWTH
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. RISING PREVALENCE OF CARDIOVASCULAR DISEASES AND VASCULAR DISORDERS
3.1.2. ADVANCEMENTS IN TISSUE ENGINEERING AND REGENERATIVE MEDICINE
3.1.3. GROWING GERIATRIC POPULATION AND CHANGING LIFESTYLES
3.2. KEY RESTRAINTS
3.2.1. HIGH COSTS ASSOCIATED WITH THE DEVELOPMENT AND COMMERCIALIZATION OF ARTIFICIAL BLOOD VESSELS
3.2.2. STRINGENT REGULATORY APPROVALS AND CLINICAL TRIAL REQUIREMENTS
3.2.3. CONCERNS REGARDING BIOCOMPATIBILITY AND LONG-TERM DURABILITY
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.1.1. DEVELOPMENT OF 3D BIOPRINTING TECHNIQUES FOR CUSTOMIZED VASCULAR GRAFTS
4.1.2. INCORPORATION OF NANOTECHNOLOGY AND BIOMIMETIC MATERIALS FOR IMPROVED FUNCTIONALITY
4.2. PESTLE ANALYSIS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.4.1. GROWTH PROSPECT MAPPING FOR SWITZERLAND
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS
4.7. VALUE CHAIN ANALYSIS
4.7.1. RAW MATERIALS
4.7.2. MANUFACTURERS
4.7.3. DISTRIBUTORS
4.7.4. END-USER
4.8. KEY BUYING CRITERIA
4.8.1. BIOCOMPATIBILITY
4.8.2. DURABILITY AND LONGEVITY
4.8.3. CUSTOMIZATION AND VERSATILITY
4.8.4. REGULATORY COMPLIANCE AND QUALITY ASSURANCE
5. MARKET BY TYPE
5.1. EXPANDED POLYTETRAFLUOROETHYLENE (EPTFE)
5.2. POLYETHYLENE TEREPHTHALATE (PET)
5.3. POLYURETHANE
5.4. OTHER TYPES
6. MARKET BY BLOOD VESSEL DIAMETER
6.1. LARGE
6.2. MEDIUM
6.3. SMALL
7. MARKET BY PATIENT DEMOGRAPHICS
7.1. PEDIATRIC
7.2. ADULT
8. MARKET BY APPLICATION
8.1. PERIPHERAL ARTERY
8.2. HEMODIALYSIS
8.3. AORTIC DISEASE
9. MARKET BY END-USER
9.1. HOSPITAL
9.2. SPECIALTY CLINIC
9.3. AMBULATORY SURGICAL CENTER
9.4. OTHER END-USERS
10. COMPETITIVE LANDSCAPE
10.1. KEY STRATEGIC DEVELOPMENTS
10.1.1. MERGERS & ACQUISITIONS
10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
10.1.3. PARTNERSHIPS & AGREEMENTS
10.1.4. BUSINESS EXPANSIONS & DIVESTITURES
10.2. COMPANY PROFILES
10.2.1. B BRAUN MELSUNGEN AG
10.2.1.1. COMPANY OVERVIEW
10.2.1.2. PRODUCT LIST
10.2.1.3. STRENGTHS & CHALLENGES
10.2.2. BECTON DICKINSON AND COMPANY
10.2.2.1. COMPANY OVERVIEW
10.2.2.2. PRODUCT LIST
10.2.2.3. STRENGTHS & CHALLENGES
10.2.3. TERUMO MEDICAL CORPORATION
10.2.3.1. COMPANY OVERVIEW
10.2.3.2. PRODUCT LIST
10.2.3.3. STRENGTHS & CHALLENGES
10.2.4. W L GORE AND ASSOCIATES
10.2.4.1. COMPANY OVERVIEW
10.2.4.2. PRODUCT LIST
10.2.4.3. STRENGTHS & CHALLENGES
10.2.5. ROUMAI MEDICAL
10.2.5.1. COMPANY OVERVIEW
10.2.5.2. PRODUCT LIST
10.2.5.3. STRENGTHS & CHALLENGES

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – SWITZERLAND ARTIFICIAL BLOOD VESSELS
TABLE 2: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 4: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY BLOOD VESSEL DIAMETER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY BLOOD VESSEL DIAMETER, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 6: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY PATIENT DEMOGRAPHICS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY PATIENT DEMOGRAPHICS, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 8: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 10: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY END-USER, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 12: LIST OF MERGERS & ACQUISITIONS
TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 15: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

List of Figures

LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR SWITZERLAND
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: KEY BUYING CRITERIA
FIGURE 8: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, GROWTH POTENTIAL, BY TYPE, IN 2023
FIGURE 9: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY EXPANDED POLYTETRAFLUOROETHYLENE (EPTFE), 2024-2032 (IN $ MILLION)
FIGURE 10: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY POLYETHYLENE TEREPHTHALATE (PET), 2024-2032 (IN $ MILLION)
FIGURE 11: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY POLYURETHANE, 2024-2032 (IN $ MILLION)
FIGURE 12: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY OTHER TYPES, 2024-2032 (IN $ MILLION)
FIGURE 13: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, GROWTH POTENTIAL, BY BLOOD VESSEL DIAMETER, IN 2023
FIGURE 14: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY LARGE, 2024-2032 (IN $ MILLION)
FIGURE 15: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY MEDIUM, 2024-2032 (IN $ MILLION)
FIGURE 16: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY SMALL, 2024-2032 (IN $ MILLION)
FIGURE 17: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, GROWTH POTENTIAL, BY PATIENT DEMOGRAPHICS, IN 2023
FIGURE 18: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY PEDIATRIC, 2024-2032 (IN $ MILLION)
FIGURE 19: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY ADULT, 2024-2032 (IN $ MILLION)
FIGURE 20: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2023
FIGURE 21: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY PERIPHERAL ARTERY, 2024-2032 (IN $ MILLION)
FIGURE 22: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY HEMODIALYSIS, 2024-2032 (IN $ MILLION)
FIGURE 23: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY AORTIC DISEASE, 2024-2032 (IN $ MILLION)
FIGURE 24: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, GROWTH POTENTIAL, BY END-USER, IN 2023
FIGURE 25: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY HOSPITAL, 2024-2032 (IN $ MILLION)
FIGURE 26: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY SPECIALTY CLINIC, 2024-2032 (IN $ MILLION)
FIGURE 27: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY AMBULATORY SURGICAL CENTER, 2024-2032 (IN $ MILLION)
FIGURE 28: SWITZERLAND ARTIFICIAL BLOOD VESSELS MARKET, BY OTHER END-USERS, 2024-2032 (IN $ MILLION)

Inkwood Researchは広範な市場を対象にし、また主要地域/国別の市場調査レポートで世界中の企業に活用されているインドに本社をおく市場調査会社です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

世界市場レポート

地域別レポート

国別レポート

ご購入に関するご案内

価格・納期について

• 価格
  • 2023年7月より全レポートの価格が値上げされました。弊社ウェブサイトでは旧価格が掲載されているページもございますが、2023年6月以前に出版されたレポートにも値上げが適用されます。予めご了承ください。
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
    • 印刷不可設定のPDFです。
  • コーポレートライセンス
    • 同一企業および関連会社間人数無制限でレポートファイルをご共有可能です。
    • PDF（印刷可能）とExcelをご提供いたします。
• 納期
  • ご注文後3-4営業日以内

• 納品形態
  • Eメール

注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでのご注文をお待ちしております。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

Inkwood Research出版の市場調査レポートに関するご質問やサンプルページのご依頼等はいつでもお気軽にお問合せください。

Inkwood Research 出版レポート一覧